EMBL, Heidelberg, Germany.
Nat Protoc. 2018 Jun;13(6):1465-1487. doi: 10.1038/nprot.2018.042. Epub 2018 May 24.
Gene tagging with fluorescent proteins is essential for investigations of the dynamic properties of cellular proteins. CRISPR-Cas9 technology is a powerful tool for inserting fluorescent markers into all alleles of the gene of interest (GOI) and allows functionality and physiological expression of the fusion protein. It is essential to evaluate such genome-edited cell lines carefully in order to preclude off-target effects caused by (i) incorrect insertion of the fluorescent protein, (ii) perturbation of the fusion protein by the fluorescent proteins or (iii) nonspecific genomic DNA damage by CRISPR-Cas9. In this protocol, we provide a step-by-step description of our systematic pipeline to generate and validate homozygous fluorescent knock-in cell lines.We have used the paired Cas9D10A nickase approach to efficiently insert tags into specific genomic loci via homology-directed repair (HDR) with minimal off-target effects. It is time-consuming and costly to perform whole-genome sequencing of each cell clone to check for spontaneous genetic variations occurring in mammalian cell lines. Therefore, we have developed an efficient validation pipeline of the generated cell lines consisting of junction PCR, Southern blotting analysis, Sanger sequencing, microscopy, western blotting analysis and live-cell imaging for cell-cycle dynamics. This protocol takes between 6 and 9 weeks. With this protocol, up to 70% of the targeted genes can be tagged homozygously with fluorescent proteins, thus resulting in physiological levels and phenotypically functional expression of the fusion proteins.
基因标记与荧光蛋白对于研究细胞蛋白的动态特性至关重要。CRISPR-Cas9 技术是将荧光标记物插入感兴趣基因(GOI)所有等位基因的强大工具,并且允许融合蛋白的功能和生理表达。为了排除(i)荧光蛋白插入不正确、(ii)荧光蛋白对融合蛋白的干扰或(iii)CRISPR-Cas9 对非特异性基因组 DNA 的损伤等脱靶效应,仔细评估此类经过基因组编辑的细胞系是至关重要的。在本方案中,我们提供了一个系统的流程,用于生成和验证纯合荧光敲入细胞系。我们使用配对的 Cas9D10A 切口酶通过同源定向修复(HDR)有效地将标签插入特定的基因组位点,从而最小化脱靶效应。对每个细胞克隆进行全基因组测序以检查哺乳动物细胞系中自发发生的遗传变异既耗时又昂贵。因此,我们开发了一种生成的细胞系的有效验证流程,包括连接 PCR、Southern 印迹分析、Sanger 测序、显微镜、Western 印迹分析和用于细胞周期动态的活细胞成像。该方案需要 6 到 9 周的时间。使用该方案,高达 70%的靶向基因可以用荧光蛋白进行纯合标记,从而导致融合蛋白的生理水平和表型功能表达。